Amplia Therapeutics Limited (ASX:ATX)

Amplia Therapeutics Revenue

In the fiscal year ending March 31, 2025, Amplia Therapeutics had annual revenue of 3.78M AUD, down -15.03%. Amplia Therapeutics had revenue of 2.38M in the half year ending March 31, 2025, a decrease of -509.87%.

• Revenue: 3.78M
• Revenue Growth: -15.03%
• P/S Ratio: 23.69
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 89.62M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	3.78M	-669.04K	-15.03%
Mar 31, 2024	4.45M	3.26M	274.34%
Mar 31, 2023	1.19M	-793.83K	-40.03%
Mar 31, 2022	1.98M	449.80K	29.33%
Mar 31, 2021	1.53M	1.50M	4,380.44%